Evidence map›Paper›PMID 41359631›Full record

ArticlePloS one2025

Inflammatory cytokines promote interferon regulatory factor (IRF) transcriptional activity in human pulmonary epithelial cells through the induction of IRF1 by nuclear factor-κB.

Amandah Necker-Brown, Mahmoud M Mostafa, Andrei Georgescu, Andrew J Thorne, Priyanka Chandramohan, Cora Kooi, Keerthana Kalyanaraman, Alex Gao, Akanksha Bansal, Sarah K Sasse and 3 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Amandah Necker-BrownDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0009-0009-9370-3525
Mahmoud M MostafaDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0001-6377-911X
Andrei GeorgescuDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Andrew J ThorneDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0009-0009-1519-6126
Priyanka ChandramohanDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Cora KooiDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Keerthana KalyanaramanDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Alex GaoDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Akanksha BansalDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Sarah K SasseDepartment of Medicine, National Jewish Health, Denver, Colorado, United States of America.
Anthony N GerberDepartment of Medicine, National Jewish Health, Denver, Colorado, United States of America.
Richard LeighDepartment of Medicine, Lung Health Research Group, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0009-0007-8959-2899
Robert NewtonDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.ORCID https://orcid.org/0000-0002-4919-8498

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferon regulatory factors (IRFs) play key roles during viral and bacterial infections. However, their regulation by inflammatory cytokines, including interleukin (IL)-1β and tumor necrosis factor (TNF) α, remains underexplored. As airway epithelial cells (AECs) modulate lung inflammation, IRF expression was characterized in pulmonary A549 and bronchial BEAS-2B epithelial cells along with primary AECs grown in submersion, or air-liquid interface, culture. While, IRF6 mRNA was only highly expressed in primary cells, IRF4 and IRF8 mRNAs were consistently low across the models. All the other IRF mRNAs were expressed in each model. IRF3 and IRF9 mRNAs were highly expressed, but their proteins remained primarily cytoplasmic post-IL-1β treatment in A549 cells. IRF2 showed moderate/high mRNA expression and was constitutively nuclear. However, RNA silencing did not support roles for IRF2 or IRF3, with only a modest role for IRF9, in the IL-1β-induced activation of an IRF reporter. IRF1 mRNA was highly induced by IL-1β in A549 and primary cells. Similarly, IRF1 protein was increased by IL-1β and TNFα in A549 cells, and by TNFα in BEAS-2B cells. In A549 cells, IL-1β-induced IRF1 protein localized to the nucleus and since IRF1 silencing prevented IRF reporter activity, a major transcriptional role was indicated. Mechanistically, the inflammatory transcription factor, nuclear factor (NF)-κB, was necessary for IL-1β- and TNFα-induced IRF1 expression. Further, four novel enhancer regions 5' to IRF1 bound the NF-κB subunit, p65, and their IL-1β/TNFα-induced reporter activity required consensus NF-κB motifs. Three such regions recruited RNA polymerase-2 and were flanked by the active chromatin mark, histone 3 lysine 27 acetylation, supporting enhancer involvement in IRF1 transcription. Finally, IRF1 expression, transcription rate, and enhancer activity induced by IL-1β, or TNFα, were relatively unaffected by glucocorticoid. IRF1-dependent gene expression may therefore show insensitivity to glucocorticoid and could contribute to glucocorticoid-resistance in diseases that include severe asthma.

Indexed as

CytokinesEpithelial CellsInterferon Regulatory Factor-1Interferon Regulatory FactorsLungNF-kappa BTranscription, GeneticA549 CellsCell LineHumansInterleukin-1betaRNA, MessengerTumor Necrosis Factor-alphaCytokinesInterferon Regulatory Factor-1Interferon Regulatory FactorsInterleukin-1betaIRF1 protein, humanNF-kappa BRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID41359631
PMCPMC12685198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.